Dr Lal Pathlabs Ltd Share Price
(LALPATHLAB)
Check the latest share price of Dr Lal Pathlabs Ltd, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.
as on 04:01PM, 02 May 2025
NSE
Dr Lal Pathlabs Ltd Performance
Get real-time share price information, day’s high and low, historical returns and market stats.
Day's Low
Day's High
₹2,722.7Day's Price Range₹2,839.752 Week's Low
52 Week's High
₹2,201.252-Week Price Range₹3,653.95
| Returns % | |
| 1 Month Return | + 10.89 % |
| 3 Month Return | -1.71 % |
| 1 Year Return | + 17.85 % |
| Market Stats | |
| Previous Close | ₹2,769.10 |
| Open | ₹2,763.00 |
| Volume | 1.38L |
| Upper Circuit | ₹3,322.90 |
| Lower Circuit | ₹2,215.30 |
| Market Cap | ₹23,147.39Cr |
Dr Lal Pathlabs Ltd Fundamentals & Key Indicators
Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.
Market Cap
₹23,147.39 Cr
Return on Equity (ROE)
21.42
PE Ratio (TTM)
47.35
Return on capital employed (ROCE)
25.77
Beta (LTM)
0.47
P/B Ratio
9.94
Dividend Yield
0.8
PEG Ratio
3.06
EPS (TTM)
43.4
Sector
Healthcare
Technical Analysis
Bullish
View Technical Analysis
How to invest in Dr Lal Pathlabs Ltd
Investing in Dr Lal Pathlabs Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Dr Lal Pathlabs Ltd or LALPATHLAB on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Dr Lal Pathlabs Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Dr Lal Pathlabs Ltd with just a few clicks!
Dr Lal Pathlabs Ltd Valuation
Track how the P/E of Dr Lal Pathlabs Ltd has moved over time to understand valuation trends.
Dr Lal Pathlabs Ltd in the last 5 years
Lowest (37.51x)
November 16, 2018
Today (47.35x)
April 30, 2025
Industry (101.44x)
April 30, 2025
Highest (95.62x)
November 5, 2020
Today’s Price to Earnings Ratio: 47.35x
Analysts Recommendation on Dr Lal Pathlabs Ltd
Get updated buy, sell, and hold recommendations by analysts on Dr Lal Pathlabs Ltd.
based on 23 analysts
62.50%
Buy
8.33%
Hold
29.17%
Sell
62.5% of analysts recommend a 'HOLD' rating for Dr Lal Pathlabs Ltd. Average target price of ₹3085.91
Source: S&P Global Market Intelligence
Analysts Forecast on Dr Lal Pathlabs Ltd
Get share price movements and forecasts by analysts on Dr Lal Pathlabs Ltd.
Dr Lal Pathlabs Ltd price forecast by 23 analysts
Upside of11.44%
High
₹3770
Target
₹3085.91
Low
₹2110
Dr Lal Pathlabs Ltd target price ₹3085.91, a slight upside of 11.44% compared to current price of ₹2793.6. According to 23 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Dr Lal Pathlabs Ltd revenue growth forecast
Expected growth rate Q1, FY2027:38.87%
Forecast
Actual
Including amortisation and stock based compensations
Dr Lal Pathlabs Ltd EPS growth forecast
EPS estimate Q1, FY2027:62.33%
Forecast
Actual
Source: S&P Global Market Intelligence
Dr Lal Pathlabs Ltd Financials
Get the annual and quarterly financial summary of Dr Lal Pathlabs Ltd, including revenue, profit, loss and more.
Dr Lal Pathlabs Ltd Index Inclusions
Dr Lal Pathlabs Ltd Earnings and Dividends
View detailed summary of the earnings and dividend history of Dr Lal Pathlabs Ltd.
Dr Lal Pathlabs Ltd Earnings Results
Dr Lal Pathlabs Ltd’s net profit jumped 83.2% since last year same period to ₹154.80Cr in the Q4 2024-2025. On a quarterly growth basis, Dr Lal Pathlabs Ltd has generated 60.08% jump in its net profits since last 3-months.
Read More about Earnings ResultsDr Lal Pathlabs Ltd Dividends January,2025
In the quarter ending December 2024, Dr Lal Pathlabs Ltd has declared dividend of ₹6 - translating a dividend yield of 1.29%.
Read More about Dividends
Dr Lal Pathlabs Ltd Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Dr Lal Pathlabs Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 53.91% | 0.00 | |
| Foreign Institutions | 23.91% | 0.00 | |
| Mutual Funds | 12.84% | 0.00 | |
| Retail Investors | 5.84% | 0.00 | |
| Others | 3.51% | 0.00 |
Dr Lal Pathlabs Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Dr Lal Pathlabs Ltd with its industry peers.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| HOLD | ₹23,147.39 Cr | 16.11% | 0.55 | ₹362 Cr | ₹2,226 Cr | |
| HOLD | ₹32,562.76 Cr | 103.31% | 0.67 | ₹168 Cr | ₹5,040 Cr | |
| HOLD | ₹61,169.45 Cr | 18.41% | 0.56 | ₹1,811 Cr | ₹12,667 Cr | |
| BUY | ₹10,268.76 Cr | 12.27% | 0.64 | ₹119 Cr | ₹547 Cr | |
| BUY | ₹4,653.35 Cr | 15.46% | 0.54 | ₹69 Cr | ₹571 Cr |
Dr Lal Pathlabs Ltd News & Key Events
Latest news and events at one place to help you take investing decisions in Dr Lal Pathlabs Ltd.
Dr Lal PathLabs Faces Margin Pressure Amid Growth Strategy - 01 May, 2025
Dr Lal PathLabs reported strong profit growth but faces near-term margin compression due to strategic investments. Analysts downgraded the stock, citing profitability concerns. Despite this, the company maintains a robust financial position with no debt and plans for geographic expansion.Dr Lal PathLabs Targets Growth and Margin Stability - 29 Apr, 2025
Dr Lal PathLabs aims for a 27% margin in FY26 while planning to expand its network by opening 15-20 new labs. The company reported a cash balance of INR 12.3 billion for future investments and M&A opportunities.Dr Lal Pathlabs Reports Strong Q4 Amid Margin Concerns - 28 Apr, 2025
Dr Lal Pathlabs reported a 10.5% rise in Q4 net sales and an 83.2% increase in profit. However, the stock fell due to mixed brokerage outlooks and anticipated margin pressures from expansion plans.Dr Lal PathLabs Reports Strong Q4 Results and Dividend - 25 Apr, 2025
Dr Lal PathLabs announced a robust Q4FY25 with an 83% profit increase to ₹155 crore, alongside a ₹6 final dividend. Growth driven by expanded testing volumes and geographic reach.Dr Lal PathLabs Announces Upcoming Dividend Consideration - 18 Apr, 2025
Dr Lal PathLabs will hold a board meeting on April 25, 2025, to discuss quarterly results and consider recommending a final dividend for FY25. The company previously declared a third interim dividend of Rs 6 per share in January 2025, following a strong Q3 performance with a 19% increase in profit after tax.Dr. Lal PathLabs Launches Advanced Amyloidosis Test - 15 Apr, 2025
Dr. Lal PathLabs has introduced a breakthrough test for amyloidosis, becoming the first diagnostic chain in South Asia to offer this advanced service, enhancing diagnostic accuracy and treatment options.
Insights on Dr Lal Pathlabs Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRetail Holding Up
Retail Investor have increased holdings from 5.82% to 5.84% in Mar 2025 quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, 96.7 Cr → 154.8 Cr (in ₹), with an average increase of 37.5% per quarter
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 10.25% to 12.84% in Mar 2025 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 621.8 Cr → 628.4 Cr (in ₹), with an average increase of 1.1% per quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 53.91% of holdings in Mar 2025 quarter
- NO EFFECT
Against Peers
In the last 1 year, Fortis Healthcare Ltd has given 55.7% return, outperforming this stock by 37.9%
- NO EFFECT
Against Peers
In the last 3 years, Max Healthcare Institute Ltd has given 180.6% return, outperforming this stock by 169.4%
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 26.82% to 23.91% in Mar 2025 quarter
- NEGATIVE IMPACT
Price Dip
In the last 7 days, LALPATHLAB stock has moved down by -4.9%
About Dr Lal Pathlabs Ltd
The company's top products include pathology tests, imaging tests, and preventive health check-ups. Its popular brands include Dr Lal PathLabs, Lal PathLabs, and Lal PathLabs Diagnostics. Dr Lal PathLabs Ltd has over 2000 labs across India, with more than 2000 collection centers, and over 20000 trained professionals. The company is also present in Nepal, Sri Lanka, and Bangladesh.
Dr Lal PathLabs Ltd is committed to providing quality healthcare services and products to its customers. It is ISO 9001:2015 certified and has been accredited by the National Accreditation Board for Testing and Calibration Laboratories (NABL).
Revenue: ₹602.60Cr as on March 2025 (Q1 25)
Net Profit: ₹155.50Cr as on March 2025 (Q1 25)
Listing date: 23 Dec, 2015
Chairperson Name: Arvind Lal
| Organisation | Dr Lal Pathlabs Ltd |
| Headquarters | Gurgaon |
| Industry | Healthcare |
| E-voting on shares | Click here to vote |
Indian Mutual Funds that own Dr Lal Pathlabs Ltd
Check out the Mutual Funds with significant holdings in Dr Lal Pathlabs Ltd.
FAQs
What is Dr Lal Pathlabs Ltd price today?
Dr Lal Pathlabs Ltd share price today stands at ₹2793.6, Open: ₹2763, Previous Close: ₹2769.1, High: ₹2839.7, Low: ₹2722.7, 52 Week High: ₹3653.95, 52 Week Low: ₹2201.2.
How to Buy Dr Lal Pathlabs Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Dr Lal Pathlabs Ltd shares
What are today's traded volumes of Dr Lal Pathlabs Ltd?
Today's traded volume of Dr Lal Pathlabs Ltd(LALPATHLAB) is 1.38L.
What is today's market capitalisation of Dr Lal Pathlabs Ltd?
Today's market capitalisation of Dr Lal Pathlabs Ltd(LALPATHLAB) is ₹23,147.39 Cr.
What is the 52 Week High and Low Range of Dr Lal Pathlabs Ltd?
How much percentage Dr Lal Pathlabs Ltd is down from its 52 Week High?
Dr Lal Pathlabs Ltd (LALPATHLAB) share price is ₹2793.6. It is down -23.55% from its 52 Week High price of ₹3653.95
How much percentage Dr Lal Pathlabs Ltd is up from its 52 Week low?
Dr Lal Pathlabs Ltd (LALPATHLAB) share price is ₹2793.6. It is up 26.91% from its 52 Week Low price of ₹2201.2